The skin is the largest organ of the human body. Its functions are prevention of electrolyte and water losses that compromise health; sensory reception for touch, pain, cold, and warmth; and protection from germs. The skin is made up of three layers: the epidermis, dermis, and subcutis. The layer that is associated with skin cancer is the epidermis. The most common cancers of the skin occur to the basal cells and squamous cells of the epidermis.
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The skin is the largest organ of the human body. Its functions are prevention of electrolyte and water losses that compromise health; sensory reception for touch, pain, cold, and warmth; and protection from germs. The skin is made up of three layers: the epidermis, dermis, and subcutis. The layer that is associated with skin cancer is the epidermis. The most common cancers of the skin occur to the basal cells and squamous cells of the epidermis.
Cancers in these cells are known as nonmelanoma skin cancers. The other type of skin cancer is malignant melanoma, and this cancer form originates in the melanocytes, which are found in the lower epidermis. Cancerous melanoma is curable in the beginning stages, but there is a possibility of it spreading to other areas of the body. Skin cancer is the most common of all cancer types, and more than 1 million new cases will be diagnosed this year in the United States. Eighty percent of these new skin cancers will be basal cell, 16% will be squamous cell, and 4% melanoma. There is a better than 95% chance of curing basal-and squamous-cell cancers if they are found in the early stages. The real danger lies in malignant melanoma, which accounts for more than 80% of skin-cancer deaths. Its incidence has increased by 1,900% since the 1930s, has tripled since 1980, and is rising at more than 9% per year. It is increasing in young women between the ages of 25 and 29 years. Currently, the lifetime risk for developing malignant melanoma is 1 in 79. The estimated number of new cases will exceed 52,000 in 2002. It is estimated that malignant melanomas will be found in 29,000 men and 24,000 women. Of these 52,000 new cases, 7,800 people will die. One person dies each hour from it. These statistics are alarming, especially with many of the physically active population exercising and participating in various outdoor sports and other activities.
The purpose of this article is to provide an overview of cancers of the skin in the physically active population and skin-cancer prevention strategies in the populations you serve.
Risk Factors for Skin Cancer
There are several known risk factors for melanoma skin cancer. A history of skin cancer in the immediate family (parents or siblings) increases one's risk of developing the disease. Light-colored hair, freckles, light skin pigmentation, and large skin moles continue to be risk factors. Exposing oneself to ultraviolet sun rays for extended periods of time without the use of sunscreen increases one's risk. There is a cumulative effect of multiple sunburns over many, many years that increases the risk of skin cancer developing. Two other risk factors, immunosuppression and xeroderma pigmentosum, are more rare and are oftentimes associated with other issues of deteriorating health. Immunosuppression occurs in people who have or are being treated for illnesses that have as a side effect the inhibition of the immune system. Xeroderma pigmentosum is a rare genetic health problem that renders a person's body unable to repair sun damage to the skin.
Is It or Is It Not Skin Cancer?
Recognizing skin cancer can be quite simple. The American Academy of Dermatology and the American Cancer Society recommend using the acronym ABCD to analyze changes in the skin. The A stands for asymmetry. If one half of the mole matches the other half, it is not skin cancer; if it does not match, then there is a risk that it is skin cancer. B is for border irregularity. If the borders of the mole are sketchy or not well defined, this is a warning sign of skin cancer. The C stands for color. The pigmentation should be uniform; if it is not and instead includes red, white, or blue colors mixed with black, tan, or brown variations, these are also warning signs. D is for diameter. A normal mole should be smaller than a pencil eraser. A mole that is larger should be checked by a dermatologist. Any mole that rapidly appears or a previous mole that experiences changes in its ABCDs should be checked by a physician immediately.
Diagnosing Skin Cancer
Skin-cancer diagnosis involves a history and physical exam by a physician, a skin biopsy, and the application of a staging protocol for the melanoma. When taking the medical history, the physician takes note of the age of the patient, the timing of the abnormal skin area, any noted changes, previous exposure to skin-cancer-causing agents, and a family history of skin cancer. He or she then physically examines the area, checks it for bleeding, and notes its shape, texture, scaling, size, and color. The lymph nodes will also be examinedenlarged lymph nodes are indicative of melanoma. Next the physician will take a skin biopsy. There are different ways in which the skin can be biopsied. Any biopsy will leave a scar, so the patient and doctor must discuss the procedure and expectations for healing. The four types of biopsies are the shave, the punch, incision, and excision. All biopsies require a local anesthetic. Once the area is numb, the physician performs the biopsy and sends the biopsied tissue to a medical laboratory for testing and analysis. If the tissue is found to be cancerous, the skin cancer will undergo a staging process to determine whether it has spread to other areas of the body.
The staging for melanoma is done with a system that uses the acronym TNM. T is for the thickness of the tumor. The N stands for nodes and represents whether the cancer has spread to the lymph nodes. The M stands for metastasis to the organs of the body. Each of the TNM stagings is given a zero or a Roman numeral from I to IV. The higher the numeral, the more the cancer has spread. Table 1 explains the stage ratings. Survival rates decline as the staging number increases: The survival rates are 97%, 90%, 80%, 50%, and 20% for Stages 0-IV, respectively.
Treating Skin Cancer
The treatment for malignant melanoma varies according to the staging. Stages 0 and I result in removal of healthy skin equal to or greater than the involved tissue. Stage II also involves removal of seemingly healthy tissue. There are two trains of thought regarding the lymph nodes during Stage II: One is removal to prevent the melanoma from spreading, and the other is to leave the lymph nodes alone and monitor 
I
The tumor is thin (less than 1.5 mm) and localized, not yet having spread to the lymph nodes or organs.
II
The tumor is thicker than 1.5 mm but remains localized and has still not spread to the lymph nodes or organs.
III
The lymph nodes nearest the melanoma are involved with cancer, but it has not spread to the organs.
IV
The melanoma has involved the lymph nodes and organs such as the liver, lungs, and brain.
